Childhood Cancer Incidence, New York State Excluding New York City, 2005-2009
Source: New York State Cancer Registry
| Site of Cancer | Ages 0-4 | Ages 5-9 | Ages 10-14 | Ages 15-19 | Combined Ages 0-14 | Combined Ages 0-19 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avg Annual Cases | Rate per 1,000,000 | Avg Annual Cases | Rate per 1,000,000 | Avg Annual Cases | Rate per 1,000,000 | Avg Annual Cases | Rate per 1,000,000 | Avg Annual Cases | Rate per 1,000,000 | 95% CI (+/-) | Avg Annual Cases | Rate per 1,000,000 | 95% CI (+/-) | |
| All Invasive Malignant Tumors | 158.0 | 244.2 | 84.6 | 122.1 | 100.4 | 131.5 | 197.0 | 231.1 | 343.0 | 164.7 | 7.8 | 540.0 | 181.4 | 6.9 |
| I Leukemias | 59.0 | 91.2 | 25.8 | 37.2 | 20.2 | 26.5 | 24.4 | 28.6 | 105.0 | 50.9 | 4.4 | 129.4 | 45.3 | 3.5 |
| I(a) Lymphoid leukemias | 47.2 | 73.0 | 21.4 | 30.9 | 14.4 | 18.9 | 12.8 | 15.0 | 83.0 | 40.3 | 3.9 | 95.8 | 33.9 | 3.0 |
| I(b) Acute myeloid leukemia | 7.6 | 11.7 | 2.4 | 3.5 | 3.0 | 3.9 | 5.6 | 6.6 | 13.0 | 6.3 | 1.5 | 18.6 | 6.4 | 1.3 |
| II Lymphomas and reticuloendothelial neoplasms | 6.0 | 9.3 | 11.4 | 16.4 | 20.4 | 26.7 | 50.0 | 58.7 | 37.8 | 17.6 | 2.5 | 87.8 | 28.0 | 2.6 |
| II(a) Hodgkin lymphoma | 0.4 | 0.6 | 2.4 | 3.5 | 11.6 | 15.2 | 32.8 | 38.5 | 14.4 | 6.5 | 1.5 | 47.2 | 14.6 | 1.9 |
| II(b,c,d) Non-Hodgkin lymphomas | 5.2 | 8.0 | 9.0 | 13.0 | 8.8 | 11.5 | 17.0 | 19.9 | 23.0 | 10.9 | 2.0 | 40.0 | 13.2 | 1.8 |
| III CNS & misc intracranial & intraspinal neoplasms | 30.2 | 46.7 | 24.8 | 35.8 | 23.0 | 30.1 | 24.8 | 29.1 | 78.0 | 37.4 | 3.7 | 102.8 | 35.3 | 3.1 |
| III(a) Ependymomas and choroid plexus tumor | 3.4 | 5.3 | 1.6 | 2.3 | 1.2 | 1.6 | 2.0 | 2.3 | 6.2 | 3.0 | 1.1 | 8.2 | 2.8 | 0.9 |
| III(b) Astrocytoma | 15.2 | 23.5 | 13.2 | 19.0 | 14.8 | 19.4 | 14.0 | 16.4 | 43.2 | 20.6 | 2.7 | 57.2 | 19.5 | 2.3 |
| III(c) Intracranial and intraspinal embryonal tum | 8.0 | 12.4 | 4.0 | 5.8 | 2.8 | 3.7 | 1.8 | 2.1 | 14.8 | 7.2 | 1.6 | 16.6 | 5.9 | 1.3 |
| III(d) Other gliomas | 2.6 | 4.0 | 4.8 | 6.9 | 3.4 | 4.5 | 4.8 | 5.6 | 10.8 | 5.1 | 1.4 | 15.6 | 5.3 | 1.2 |
| IV Neuroblastoma and other peripheral nervous cell tumors | 20.2 | 31.2 | 2.2 | 3.2 | 0.4 | 0.5 | 0.6 | 0.7 | 22.8 | 11.3 | 2.1 | 23.4 | 8.7 | 1.6 |
| IV(a) Neuroblastoma and ganglioneuroblastoma | 20.2 | 31.2 | 2.2 | 3.2 | 0.4 | 0.5 | 0.4 | 0.5 | 22.8 | 11.3 | 2.1 | 23.2 | 8.6 | 1.6 |
| V Retinoblastoma | 7.8 | 12.1 | 0.6 | 0.9 | 0.0 | 0.0 | 0.0 | 0.0 | 8.4 | 4.2 | 1.3 | 8.4 | 3.1 | 0.9 |
| VI Renal tumors | 13.2 | 20.4 | 3.0 | 4.3 | 1.2 | 1.6 | 1.4 | 1.6 | 17.4 | 8.6 | 1.8 | 18.8 | 6.8 | 1.4 |
| VI(a) Nephroblastoma and other nonepithelial rena | 13.2 | 20.4 | 2.8 | 4.0 | 0.8 | 1.0 | 0.2 | 0.2 | 16.8 | 8.3 | 1.8 | 17.0 | 6.3 | 1.3 |
| VII Hepatic tumors | 5.2 | 8.0 | 0.8 | 1.2 | 0.8 | 1.0 | 1.4 | 1.6 | 6.8 | 3.3 | 1.1 | 8.2 | 2.9 | 0.9 |
| VII(a) Hepatoblastoma | 5.2 | 8.0 | 0.2 | 0.3 | 0.4 | 0.5 | 0.0 | 0.0 | 5.8 | 2.9 | 1.0 | 5.8 | 2.2 | 0.8 |
| VIII Malignant bone tumors | 0.6 | 0.9 | 5.4 | 7.8 | 7.8 | 10.2 | 11.8 | 13.8 | 13.8 | 6.4 | 1.5 | 25.6 | 8.3 | 1.4 |
| VIII(a) Osteosarcoma | 0.0 | 0.0 | 2.4 | 3.5 | 3.4 | 4.5 | 6.6 | 7.7 | 5.8 | 2.7 | 1.0 | 12.4 | 4.0 | 1.0 |
| VIII(c) Ewing tumor and related sarcomas of bone | 0.6 | 0.9 | 2.6 | 3.8 | 3.0 | 3.9 | 3.6 | 4.2 | 6.2 | 2.9 | 1.0 | 9.8 | 3.2 | 0.9 |
| IX Soft tissue and other extraosseous sarcomas | 8.2 | 12.7 | 6.0 | 8.7 | 8.6 | 11.3 | 15.2 | 17.8 | 22.8 | 10.8 | 2.0 | 38.0 | 12.6 | 1.8 |
| IX(a) Rhabdomyosarcoma | 5.0 | 7.7 | 3.8 | 5.5 | 2.8 | 3.7 | 3.2 | 3.8 | 11.6 | 5.6 | 1.4 | 14.8 | 5.1 | 1.2 |
| X Germ cell & trophoblastic tumors & gonadal neoplasms | 5.2 | 8.0 | 1.2 | 1.7 | 6.0 | 7.9 | 27.2 | 31.9 | 12.4 | 5.9 | 1.5 | 39.6 | 12.4 | 1.7 |
| X(a) Intracranial and intraspinal germ cell tumo | 1.0 | 1.5 | 0.0 | 0.0 | 2.2 | 2.9 | 2.2 | 2.6 | 3.2 | 1.5 | 0.7 | 5.4 | 1.8 | 0.7 |
| X(c) Malignant gonadal germ cell tumor | 1.0 | 1.5 | 0.8 | 1.2 | 3.4 | 4.5 | 20.8 | 24.4 | 5.2 | 2.4 | 0.9 | 26.0 | 7.9 | 1.4 |
| XI Other malignant epithelial neoplasms and malignant melanomas | 1.6 | 2.5 | 3.4 | 4.9 | 11.8 | 15.5 | 39.4 | 46.2 | 16.8 | 7.7 | 1.7 | 56.2 | 17.4 | 2.0 |
| XI(b) Thyroid carcinoma | 0.2 | 0.3 | 0.8 | 1.2 | 5.8 | 7.6 | 20.0 | 23.5 | 6.8 | 3.1 | 1.0 | 26.8 | 8.2 | 1.4 |
| XI(d) Malignant melanoma | 0.8 | 1.2 | 1.6 | 2.3 | 2.8 | 3.7 | 10.0 | 11.7 | 5.2 | 2.4 | 0.9 | 15.2 | 4.8 | 1.1 |
| XII Other and unspecified malignant neoplasms | 0.8 | 1.2 | 0.0 | 0.0 | 0.2 | 0.3 | 0.8 | 0.9 | 1.0 | 0.5 | 0.4 | 1.8 | 0.6 | 0.4 |
Notes
- Incidence data are provisional, November 2011.
- Rates are per 1,000,000 children. Rates for 0-14 and 0-19 year age intervals are age-adjusted within these intervals to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases per year are unstable and should be used with caution.
- Non-Hodgkin lymphomas, Burkitt, and miscellaneous lymphomas are grouped together under II(b,c,d).
